
PSTHHealth
Transforming Healthcare Through AI-Driven Intelligent Systems
PSTHhealth is redefining healthcare infrastructure and improves patient outcomes through an
AI-driven compliance-first approach that embeds safety ad legal requirements proactively into all of our designs and products.
PSTHhealth develops and deploys a wide array of advanced AI-driven platforms and proprietary technologies that optimize, scale and evolve healthcare delivery.
Our design principles adhere to all regulations and FDA requirements, as well as Sarbanes-Oxley (SOX), Good Practice (GxP) data integrity requirements, and electronic record regulations such as 21 CFR Part 11.
About Our Company
Who We Are

PSThealth is a healthcare innovation company focused on designing, developing, and commercializing next-generation healthcare technologies. Our portfolio includes proprietary systems spanning AI-enhanced operational optimization, patient engagement, and healthcare infrastructure strategy.
Our Mission
To make healthcare more intelligent by improving efficiency, accessibility, and cost-effectiveness through systems that align providers, payers, and patients.
Our Vision
A fully integrated AI-driven healthcare ecosystem where data, intelligence, and automation work seamlessly together to improve healthcare delivery and operational performance.
Leadership
Founded by experienced innovators and industry leaders focused on advancing healthcare through original artificial intelligence models and scalable technology solutions.
Our Technologies
AI-Driven Pharmacy Operations Optimization and Access Preservation
Designed to:
- Forecast prescription demand and operational risk across pharmacy networks. Optimizes pharmacy operations
- Enhance reimbursement outcomes
- Preserve critical healthcare access points
AI-Enhanced Applications to Improve Pharmaceutical Industry Financial Management
Next-generation Operational Drivers that:
- Improve patient and enterprise experiences through strategic forecasting
- Optimize financial management, operations, and risk analysis
- Provide audit-ready, traceable, and explainable reporting
- Support predictive analytics for manufacturing, clinical trials, and regulatory finance
An AI-driven Chemical Risk Detection, Personalized Exposure Modeling, and Real-time Product Substitution in Consumer Food Products (Purescan AI)

A computer-implemented system and method for detecting chemical risk in consumer food products using artificial intelligence is disclosed. The system acquires product information via barcode scanning, optical character recognition of ingredient labels, image analysis, or database retrieval. Extracted ingredient data is normalized using a chemical ontology and synonym resolution to identify chemical compounds and additive patterns. A risk classification engine assigns risk scores to ingredients, which are aggregated to generate a baseline product risk score. A personalization engine adjusts the risk score based on user-specific factors, including age, health conditions, and dietary preferences.
System and Method for Duration Compression of Medical Device Clinical Trials Using AI-driven Parallelization and Predictive Validation (TCT-PV)

A system and method for reducing duration and cost of medical device clinical trials through artificial intelligence-driven temporal compression is disclosed. The system comprises a multi-source data ingestion layer configured to receive clinical, operational, and device-generated data; a predictive intelligence layer configured to model enrollment rates, protocol deviations, data completeness, and device outcomes; and a parallel execution layer configured to enable concurrent site activation, enrollment, monitoring, and data validation. An adaptive control layer dynamically adjusts trial parameters, including site allocation, cohort distribution, and protocol execution, based on real-time and predicted trial performance.
System and Method for AI-driven Early Detection of Multiple Sclerosis Using Multimodal Biomarker Fusion and Temporal Risk Modeling

A computer-implemented system and method for the early detection and risk stratification of Multiple Sclerosis are disclosed. The system is configured to acquire and process multimodal patient data, including physiological signals, behavioral interaction data, biochemical biomarkers, medical imaging data, and electronic health records.
Intellectual Property Portfolio
PSTHhealth has an expanding portfolio of US provisional and utility patent applications covering:
Forecasts may incorporate operational drivers, including:
- Patient enrollment rates
- Clinical trial site activations
- Manufacturing yields
- Regulatory timelines
- Payer reimbursement patterns, and
- Foreign exchange fluctuations.
IP Strategy
Our intellectual property is designed to:
- Create defensible market advantages
- Enable licensing and strategic partnerships
- Support scalable platform commercialization
Solutions For Healthcare Systems
Reduce operational costs
- Improve margins through optimization
- Enable strategic expansion and consolidation
- Implement value-based care models
Improve margins through optimization
- Optimize reimbursement strategies
- Improve population health outcomes
- Reduce unnecessary utilization and costs
Enable strategic expansion and consolidation
- Increase transparency
- Improve access to care
- Deliver personalized healthcare guidance
Implement value-based care models
- Access proprietary healthcare technologies
- Participate in scalable platform growth
- Leverage IP-driven market opportunities
For Payers
- Optimize reimbursement strategies
- Improve population health outcomes
- Reduce unnecessary utilization and costs
For Patients
- Increase transparency
- Improve access to care
- Deliver personalized healthcare guidance
For Partners & Investors
- Access proprietary healthcare technologies
- Participate in scalable platform growth
- Leverage IP-driven market opportunities
Why PSTHhealth?
Proprietary Innovation
We own the patented technology — not just implementing someone else’s.
System-Level Thinking
We design advanced working solutions that operate across the entire healthcare ecosystem.
Partnerships
• Healthcare systems
• Insurance providers
• Pharmacy networks
• Technology partners
• Investment groups
Engagement Models
• Technology licensing
• Strategic partnerships
• Joint ventures
• Enterprise deployments
News & Insights:
• Industry trends
• Healthcare innovation
• AI in healthcare
• Company announcements
• Research and publications






